Article
The copy number variation and stroke (CaNVAS) risk and outcome study.
PloS one - 1 Jan 2021
Cole John W, Adigun Taiwo, Akinyemi Rufus, Akpa Onoja Matthew, Bell Steven, Chen Bowang, Jimenez Conde Jordi, Lazcano Dobao Uxue, Fernandez Israel, Fornage Myriam, Gallego-Fabrega Cristina, Jern Christina, Krawczak Michael, Lindgren Arne, Markus Hugh S, Melander Olle, Owolabi Mayowa, Schlicht Kristina, Söderholm Martin, Srinivasasainagendra Vinodh, Soriano Tárraga Carolina, Stenman Martin, Tiwari Hemant, Corasaniti Margaret, Fecteau Natalie, Guizzardi Beth, Lopez Haley, Nguyen Kevin, Gaynor Brady, O'Connor Timothy, Stine O Colin, Kittner Steven J, McArdle Patrick, Mitchell Braxton D, Xu Huichun, Grond-Ginsbach Caspar
Abstract excerpt
BACKGROUND AND PURPOSE: The role of copy number variation (CNV) variation in stroke susceptibility and outcome has yet to be explored. The Copy Number Variation and Stroke (CaNVAS) Risk and Outcome study addresses this knowledge gap. METHODS: Over 24,500 well-phenotyped IS cases, including IS subtypes, and over 43,500 controls have been identified, all with readily available genotyping on GWAS and exome arrays,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.